All posts by: Michael Zand

About Michael Zand

So Far, So Good for Parkinson’s Gene Therapy – Alzforum

Continue reading

2018-03-16 NEWS

Alzforum

So Far, So Good for Parkinson’s Gene Therapy
Alzforum
Using gene therapy to boost dopamine levels in the brain could soothe the symptoms of Parkinson’s disease, according to a March 9 press release. Voyager Therapeutics of Cambridge, Massachusetts, shared interim data from an ongoing, open-label Phase 1b

Continue reading

2018-03-16 NEWS

Danaher’s Acquisition of Integrated DNA Technologies
Global Legal Chronicle (press release)
Paul Hastings LLP is serving as legal counsel to Integrated DNA Technologies, a privately-held life sciences company, in connection with a definitive agreement under which Danaher Corporation (NYSE: DHR) will acquire IDT. Danaher Corporation (NYSE: DHR